Simplify Healthcare supports Maker’s Merci in donating $5K to the American Diabetes Association to improve the lives of diabetics
September 20, 2021 14:43 ET | Simplify Healthcare
Aurora, IL, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Simplify Healthcare is proud to support its not-for-profit affiliate, Maker’s Merci in donating $5,000 to the American Diabetes Association (ADA) for...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
June 14, 2020 11:00 ET | Zealand Pharma
Press release – No. 09 / 2020   Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association...
1547522887207_5c33aa745c253600048c1b5f_logo.jpg
Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association
June 18, 2019 08:00 ET | Amarantus Bioscience Holdings, Inc.
NEW YORK, NY, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding...
LOGO-T1D.png
Finalists Announced for 2018 Diabetes Innovation Challenge
April 24, 2018 08:10 ET | T1D Exchange
BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to improve the lives of people with type 1...
T1D_stacked_color.png
Innovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation Challenge
March 20, 2018 08:15 ET | T1D Exchange
BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type...
More than One Third of Louisiana Adults Have Prediabetes, Increased Risk for Serious Health Problems
January 29, 2018 12:30 ET | Louisiana Public Health Institute
New Orleans, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Across Louisiana, more than 35 percent of adults have prediabetes and are at an increased risk for serious health complications including kidney...
Solera Health and the American Diabetes Association® Collaborate to Help Prevent and Delay Type 2 Diabetes for Millions of Americans
October 18, 2017 10:00 ET | Solera Health
PHOENIX, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Solera Health (Solera), a preventive care benefits manager, today announced that they have joined forces with the American Diabetes Association...
xeris_logo-1.png
Xeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program
June 16, 2017 07:51 ET | Xeris Pharmaceuticals, Inc.
CHICAGO, IL and AUSTIN, TX, June 16, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) announced today that results from three clinical studies of the company’s investigational...
NVLN Logo.jpg
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
June 12, 2017 08:30 ET | Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., June 12, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
larimar-ao-final.jpg
Zafgen Presents New Data Highlighting Potential of ZGN-1061 for the Treatment of Type 2 Diabetes and Obesity at the American Diabetes Association’s 77th Annual Scientific Sessions
June 10, 2017 13:00 ET | Zafgen, Inc.
-Successful Phase 1 Clinical Trial Garners Late-Breaking ADA Presentation and Supports Advancement to Phase 2 Development- -ZGN-1061 Treatment Improves Glycemic Control and Body Weight in Preclinical...